Abstracts tagged "Computed tomography (CT)"

Abstract Number: 2390 • 2012 ACR/ARHP Annual Meeting
Color Doppler Ultrasonography an Alternative to CT/MR Angiography for Identifying Large Vessel Involvement in Giant Cell Arteritis?
Andreas P. Diamantopoulos¹, Glenn Haugeberg¹ and Geirmund Myklebust², ¹Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, ²Rheumatology, Hospital of Southern Norway, Kristiansand, Norway
Background/Purpose: Large vessel involvement has been reported to be present in 20-50% of patients with giant cell arteritis (GCA). Computed tomography (CT) and magnetic resonance…
Abstract Number: 2020 • 2012 ACR/ARHP Annual Meeting
Assessment of Procedure Safety and Cannula Position in Temporomandibular Joint Puncture Evaluated by Cone Beam Computerized Tomography
Thomas K. Pedersen¹, Kasper D. Kristensen¹, Per Alstergren², Peter Stoustrup³, Annelise Küseler¹ and Troels Herlin⁴, ¹Department of Orthodontics, University of Aarhus, Aarhus C, Denmark, ²Department of Orofacial Pain and Jaw Function Faculty of Odontology, Malmö University, Malmö, Sweden, ³Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, ⁴Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Background/Purpose: Temporomandibular joint (TMJ) arthritis frequently occurs in juvenile idiopathic arthritis (JIA). Only sparse information is available concerning the inflammatory activity and the underlying biology…
Abstract Number: 1007 • 2012 ACR/ARHP Annual Meeting
High Resolution Peripheral Quantitative CT Detects Marked Differences in Metacarpal Head and Shaft and Ultra-Ultra-Distal Radius Bone Volumetric Density and Microstructure in Early Rheumatoid Arthritis
Lynne M. Feehan¹, Helen R. Buie², Linda C. Li¹, Kamran Shojania³, Cheryl Barnabe⁴ and Heather A. McKay⁵, ¹Physical Therapy, Arthritis Research Centre of Canada and University of British Columbia, Vancouver, BC, Canada, ²Mechanical Engineering, University of Calgary, Calgary, AB, Canada, ³Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁴Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, ⁵Family Practice and Orthoepedics, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Despite improvements in clinical management of rheumatoid arthritis (RA), many with early disease are still at high risk for developing periarticular erosions and osteopenia,…
Abstract Number: 722 • 2012 ACR/ARHP Annual Meeting
Systemic Sclerosis Associated Pulmonary Hypertension – Is Pulmonary Veno-Occlusive Disease As Common As They Say?
Benjamin E. Schreiber¹, Greg Keir², D. Dobarro³, Clive Handler⁴, Svetlana Nihtyanova⁵, Jay Suntharaligam⁶, Nicola Sverzelatti⁷, Graham Robinson⁶, David Hansell⁸, Athol U. Wells⁹, Christopher P. Denton¹⁰ and John G. Coghlan¹¹, ¹Royal Free Hospital NHS Foundation Trust, National Pulmonary Hypertension Service, London, United Kingdom, ²Royal Brompton Hospital, United Kingdom, ³Pulmonary Hypertension, Royal Free Hospital, London, United Kingdom, ⁴Department of Pulmonary Hypertension, The Royal Free Hospital, London, United Kingdom, ⁵Department of Rheumatology, Royal Free Hospital, Medical School, London, England, ⁶Royal United Hospital, Bath, United Kingdom, ⁷University of Parma, Parma, Italy, ⁸Royal Brompton Hospital, London, United Kingdom, ⁹Royal Brompton and Harefield NHS Foundation Trust, Department of Radiology, London, United Kingdom, ¹⁰Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, ¹¹National Pulmonary Hypertension Service, The Royal Free Hospital NHS Foundation Trust, London, United Kingdom
Background/Purpose: Recent reviews have suggested a high prevalence of pulmonary veno-occlusive disease (PVOD) amongst patients with systemic sclerosis (SSc) associated pulmonary hypertension (PH). Interlobular septal…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].